These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology. Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519 [TBL] [Abstract][Full Text] [Related]
5. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures. Rogers WK; McDowell TS IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153 [TBL] [Abstract][Full Text] [Related]
6. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys. Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of remimazolam tosylate in hysteroscopy: A randomized, single-blind, parallel controlled trial. Zhang S; Wang J; Ran R; Peng Y; Xiao Y J Clin Pharm Ther; 2022 Jan; 47(1):55-60. PubMed ID: 34655087 [TBL] [Abstract][Full Text] [Related]
8. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies. Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial. Zhu H; Su Z; Huai X; Chen C; Zhang X; Zhou J; Su D Trials; 2022 Dec; 23(1):995. PubMed ID: 36510290 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Rex DK; Bhandari R; Lorch DG; Meyers M; Schippers F; Bernstein D Dig Liver Dis; 2021 Jan; 53(1):94-101. PubMed ID: 33243567 [TBL] [Abstract][Full Text] [Related]
12. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Sheng XY; Liang Y; Yang XY; Li LE; Ye X; Zhao X; Cui YM Eur J Clin Pharmacol; 2020 Mar; 76(3):383-391. PubMed ID: 31873765 [TBL] [Abstract][Full Text] [Related]
13. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. Zhang X; Li S; Liu J BMC Anesthesiol; 2021 May; 21(1):156. PubMed ID: 34016045 [TBL] [Abstract][Full Text] [Related]
15. Sedation outcomes for remimazolam, a new benzodiazepine. Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775 [TBL] [Abstract][Full Text] [Related]
16. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent. Kim SH; Fechner J Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830 [TBL] [Abstract][Full Text] [Related]
17. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841 [TBL] [Abstract][Full Text] [Related]
18. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Tang Y; Yang X; Yu Y; Shu H; Xu J; Li R; Zou X; Yuan S; Shang Y Minerva Anestesiol; 2022 Nov; 88(11):939-949. PubMed ID: 35785930 [TBL] [Abstract][Full Text] [Related]
19. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of remimazolam tosilate combined with low-dose fentanyl for procedural sedation in obese patients undergoing gastroscopy: study protocol for a single-centre, double-blind, randomised controlled trial. Yan L; Wang X; Chen Z; Wu N; Li H; Yang B BMJ Open; 2023 Dec; 13(12):e079095. PubMed ID: 38154891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]